Option chain shows key data for Rapid Dose Therapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Rapid Dose Therapeutics.

Rapid Dose Therapeutics (OTC:RDTCF) Stock, Option Chain

Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, and cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.

Cannabis

Earnings

News

Markets

RAPID DOSE THERAPEUTICS by Rapid Dose Therapeutics Corp

RDTCF

CSE:DOSE

Rapid Dose Therapeutics Corp. (OTCPK:RDTCF) (CSE: DOSE), released its financial results for the year ended February 28, 2023, revealing revenue of CA$718,298 ($542,000), a decrease of 59% compared to CA$1.75 million in FY 2022.

Fiscal Year 2023 Financial Highlights

Rapid Dose Therapeutics FY23 Revenue Declines 59%, Here Are The Details

Rapid Dose Therapeutics Corp. (OTCPK:RDTCF) (CSE:DOSE), filed its financial results for the fiscal year ended February 28, 2022, and for the first three quarters of the 2023 fiscal year.

Rapid Dose Therapeutics FY 2022 Revenue Grows 232%, First Three Quarters Of FY 2023 Don&#39;t Look As Good

NXTTF

TSXV:LFST

Cannabis-focused e-commerce company Lifeist Wellness Inc. (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: NXTTF), previously known as Namaste Technologies, r

Comments

Rapid Dose Therapeutics

Rapid Dose Therapeutics (RDTCF) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell